Skip to main content
Top
Published in: AIDS and Behavior 1/2018

01-01-2018 | Substantive Review

Systematic Review of Interventions for Depression for People Living with HIV in Africa

Authors: Sarah M. Lofgren, Noeline Nakasujja, David R. Boulware

Published in: AIDS and Behavior | Issue 1/2018

Login to get access

Abstract

Depression interventions for individuals with HIV/AIDS in Africa are being increasingly evaluated. MEDLINE was searched using key terms: depression, Africa, and HIV, to identify depression interventions for HIV-infected adults in Africa. Perinatal women were excluded. Results were extracted and relative change in depression scores for interventions and net effect calculated. The MEDLINE search yielded 18 articles. Six of seven studies evaluating feasibility were positive, and seven of seven studies evaluating acceptability were also positive. Three studies investigated the effect of psychotherapy (% relative decrease of depressive symptoms for intervention: %net decrease compared to controls) (73%:39% decrease). Four studies investigated task-shifting of psychotherapy (47%:34% decrease). Three studies evaluated antidepressants (79%:39% decrease). Three studies investigated task-shifting of antidepressant treatment (82%:65% decrease). An exercise intervention was evaluated (66%:49% decrease). One trial investigated minocycline with non-statistically significant results. Finally, three studies investigated other psychosocial interventions (44%:21% decrease). Overall, the results highlight the need for large, randomized trials to establish efficacy as well as implementation studies.
Literature
1.
go back to reference Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2197–223.CrossRefPubMed Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2197–223.CrossRefPubMed
2.
go back to reference Patel V, Chisholm D, Parikh R, et al. Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities. Lancet. 2016;387(10028):1672–85.CrossRefPubMed Patel V, Chisholm D, Parikh R, et al. Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities. Lancet. 2016;387(10028):1672–85.CrossRefPubMed
3.
go back to reference Uthman OA, Magidson JF, Safren SA, Nachega JB. Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries: a systematic review and meta-analysis. Curr HIV/AIDS Rep. 2014;11(3):291–307.CrossRefPubMedPubMedCentral Uthman OA, Magidson JF, Safren SA, Nachega JB. Depression and adherence to antiretroviral therapy in low-, middle- and high-income countries: a systematic review and meta-analysis. Curr HIV/AIDS Rep. 2014;11(3):291–307.CrossRefPubMedPubMedCentral
4.
go back to reference Ferrari AJ, Somerville AJ, Baxter AJ, et al. Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature. Psychol Med. 2013;43(3):471–81.CrossRefPubMed Ferrari AJ, Somerville AJ, Baxter AJ, et al. Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature. Psychol Med. 2013;43(3):471–81.CrossRefPubMed
5.
go back to reference Bouhnik AD, Preau M, Vincent E, et al. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy. Antivir Ther. 2005;10(1):53–61.PubMed Bouhnik AD, Preau M, Vincent E, et al. Depression and clinical progression in HIV-infected drug users treated with highly active antiretroviral therapy. Antivir Ther. 2005;10(1):53–61.PubMed
6.
go back to reference Marconi VC, Wu B, Hampton J, et al. Early warning indicators for first-line virologic failure independent of adherence measures in a South African urban clinic. AIDS Patient Care STD. 2013;27(12):657–68.CrossRef Marconi VC, Wu B, Hampton J, et al. Early warning indicators for first-line virologic failure independent of adherence measures in a South African urban clinic. AIDS Patient Care STD. 2013;27(12):657–68.CrossRef
9.
go back to reference Abas M, Nyamayaro P, Bere T, et al. Feasibility and acceptability of a task-shifted intervention to enhance adherence to HIV medication and improve depression in people living with HIV in Zimbabwe, a low income country in Sub-Saharan Africa. AIDS Behav. 2017. doi:10.1007/s10461-016-1659-4.PubMed Abas M, Nyamayaro P, Bere T, et al. Feasibility and acceptability of a task-shifted intervention to enhance adherence to HIV medication and improve depression in people living with HIV in Zimbabwe, a low income country in Sub-Saharan Africa. AIDS Behav. 2017. doi:10.​1007/​s10461-016-1659-4.PubMed
10.
go back to reference Chibanda D, Mesu P, Kajawu L, Cowan F, Araya R, Abas MA. Problem-solving therapy for depression and common mental disorders in Zimbabwe: piloting a task-shifting primary mental health care intervention in a population with a high prevalence of people living with HIV. BMC Public Health. 2011;11:828.CrossRefPubMedPubMedCentral Chibanda D, Mesu P, Kajawu L, Cowan F, Araya R, Abas MA. Problem-solving therapy for depression and common mental disorders in Zimbabwe: piloting a task-shifting primary mental health care intervention in a population with a high prevalence of people living with HIV. BMC Public Health. 2011;11:828.CrossRefPubMedPubMedCentral
11.
go back to reference Petersen I, Hanass Hancock J, Bhana A, Govender K. A group-based counselling intervention for depression comorbid with HIV/AIDS using a task shifting approach in South Africa: a randomized controlled pilot study. J Affect Disord. 2014;158:78–84.CrossRefPubMed Petersen I, Hanass Hancock J, Bhana A, Govender K. A group-based counselling intervention for depression comorbid with HIV/AIDS using a task shifting approach in South Africa: a randomized controlled pilot study. J Affect Disord. 2014;158:78–84.CrossRefPubMed
12.
go back to reference Adams JL, Almond ML, Ringo EJ, Shangali WH, Sikkema KJ. Feasibility of nurse-led antidepressant medication management of depression in an HIV clinic in Tanzania. Int J Psychiatry Med. 2012;43(2):105–17.CrossRefPubMedPubMedCentral Adams JL, Almond ML, Ringo EJ, Shangali WH, Sikkema KJ. Feasibility of nurse-led antidepressant medication management of depression in an HIV clinic in Tanzania. Int J Psychiatry Med. 2012;43(2):105–17.CrossRefPubMedPubMedCentral
13.
go back to reference Pence BW, Gaynes BN, Atashili J, et al. Feasibility, safety, acceptability, and preliminary efficacy of measurement-based care depression treatment for HIV patients in Bamenda, Cameroon. AIDS Behav. 2014;18(6):1142–51.CrossRefPubMedPubMedCentral Pence BW, Gaynes BN, Atashili J, et al. Feasibility, safety, acceptability, and preliminary efficacy of measurement-based care depression treatment for HIV patients in Bamenda, Cameroon. AIDS Behav. 2014;18(6):1142–51.CrossRefPubMedPubMedCentral
14.
go back to reference Nakimuli-Mpungu EWK, Okello J, Alderman S, Odokonyero R, Musisi S, Mojtabai R, Mills E. Outcomes, feasibility and acceptability of a group support psychotherapeutic intervention for depressed HIV affected Adults: a pilot study. J Affect Disord. 2014;166:144–50.CrossRefPubMed Nakimuli-Mpungu EWK, Okello J, Alderman S, Odokonyero R, Musisi S, Mojtabai R, Mills E. Outcomes, feasibility and acceptability of a group support psychotherapeutic intervention for depressed HIV affected Adults: a pilot study. J Affect Disord. 2014;166:144–50.CrossRefPubMed
15.
go back to reference Hoare J, Carey P, Joska JA, Carrara H, Sorsdahl K, Stein DJ. Escitalopram treatment of depression in human immunodeficiency virus/acquired immunodeficiency syndrome: a randomized, double-blind, placebo-controlled study. J Nerv Mental Dis. 2014;202(2):133–7.CrossRef Hoare J, Carey P, Joska JA, Carrara H, Sorsdahl K, Stein DJ. Escitalopram treatment of depression in human immunodeficiency virus/acquired immunodeficiency syndrome: a randomized, double-blind, placebo-controlled study. J Nerv Mental Dis. 2014;202(2):133–7.CrossRef
16.
go back to reference Nakimuli-Mpungu E, Wamala K, Okello J, et al. Outcomes, feasibility and acceptability of a group support psychotherapeutic intervention for depressed HIV-affected Ugandan adults: a pilot study. J Affect Disord. 2014;166:144–50.CrossRefPubMed Nakimuli-Mpungu E, Wamala K, Okello J, et al. Outcomes, feasibility and acceptability of a group support psychotherapeutic intervention for depressed HIV-affected Ugandan adults: a pilot study. J Affect Disord. 2014;166:144–50.CrossRefPubMed
17.
go back to reference Nakimuli-Mpungu E, Wamala K, Okello J, et al. Group support psychotherapy for depression treatment in people with HIV/AIDS in northern Uganda: a single-centre randomised controlled trial. Lancet HIV. 2015;2(5):e190–9.CrossRefPubMed Nakimuli-Mpungu E, Wamala K, Okello J, et al. Group support psychotherapy for depression treatment in people with HIV/AIDS in northern Uganda: a single-centre randomised controlled trial. Lancet HIV. 2015;2(5):e190–9.CrossRefPubMed
18.
go back to reference Olley BO. Improving well-being through psycho-education among voluntary counseling and testing seekers in Nigeria: a controlled outcome study. AIDS Care. 2006;18(8):1025–31.CrossRefPubMed Olley BO. Improving well-being through psycho-education among voluntary counseling and testing seekers in Nigeria: a controlled outcome study. AIDS Care. 2006;18(8):1025–31.CrossRefPubMed
19.
go back to reference Ngo VK, Wagner GJ, Nakasujja N, Dickens A, Aunon F, Musisi S. Effectiveness of antidepressants and predictors of treatment response for depressed HIV patients in Uganda. Int J STD AIDS. 2015;26(14):998–1006.CrossRefPubMed Ngo VK, Wagner GJ, Nakasujja N, Dickens A, Aunon F, Musisi S. Effectiveness of antidepressants and predictors of treatment response for depressed HIV patients in Uganda. Int J STD AIDS. 2015;26(14):998–1006.CrossRefPubMed
20.
go back to reference Wagner GJ, Ngo VK, Nakasujja N, Akena D, Aunon F, Musisi S. Impact of antidepressant therapy on cognitive aspects of work, condom use, and psychosocial well-being among HIV clients in Uganda. Int J Psychiatry Med. 2014;48(3):155–66.CrossRefPubMedPubMedCentral Wagner GJ, Ngo VK, Nakasujja N, Akena D, Aunon F, Musisi S. Impact of antidepressant therapy on cognitive aspects of work, condom use, and psychosocial well-being among HIV clients in Uganda. Int J Psychiatry Med. 2014;48(3):155–66.CrossRefPubMedPubMedCentral
21.
go back to reference Gaynes BN, Pence BW, Atashili J, et al. Changes in HIV outcomes following depression care in a resource-limited setting: results from a pilot study in Bamenda, Cameroon. PLoS ONE. 2015;10(10):e0140001.CrossRefPubMedPubMedCentral Gaynes BN, Pence BW, Atashili J, et al. Changes in HIV outcomes following depression care in a resource-limited setting: results from a pilot study in Bamenda, Cameroon. PLoS ONE. 2015;10(10):e0140001.CrossRefPubMedPubMedCentral
22.
go back to reference Belenky NM, Cole SR, Pence BW, Itemba D, Maro V, Whetten K. Depressive symptoms, HIV medication adherence, and HIV clinical outcomes in Tanzania: a prospective, observational study. PLoS ONE. 2014;9(5):e95469.CrossRefPubMedPubMedCentral Belenky NM, Cole SR, Pence BW, Itemba D, Maro V, Whetten K. Depressive symptoms, HIV medication adherence, and HIV clinical outcomes in Tanzania: a prospective, observational study. PLoS ONE. 2014;9(5):e95469.CrossRefPubMedPubMedCentral
23.
go back to reference Aweto HA, Aiyegbusi AI, Ugonabo AJ, Adeyemo TA. Effects of aerobic exercise on the pulmonary functions, respiratory symptoms and psychological status of people living with HIV. J Res Health Sci. 2016;16(1):17–21.PubMed Aweto HA, Aiyegbusi AI, Ugonabo AJ, Adeyemo TA. Effects of aerobic exercise on the pulmonary functions, respiratory symptoms and psychological status of people living with HIV. J Res Health Sci. 2016;16(1):17–21.PubMed
24.
go back to reference Nakasujja N, Miyahara S, Evans S, et al. Randomized trial of minocycline in the treatment of HIV-associated cognitive impairment. Neurology. 2013;80(2):196–202.CrossRefPubMedPubMedCentral Nakasujja N, Miyahara S, Evans S, et al. Randomized trial of minocycline in the treatment of HIV-associated cognitive impairment. Neurology. 2013;80(2):196–202.CrossRefPubMedPubMedCentral
25.
go back to reference Chidrawi HC, Greeff M, Temane QM, Ellis S. Changeover-time in psychosocial wellbeing of people living with HIV and people living close to them after an HIV stigma reduction and wellness enhancement community intervention. Afr J AIDS Res. 2015;14(1):1–12.CrossRefPubMed Chidrawi HC, Greeff M, Temane QM, Ellis S. Changeover-time in psychosocial wellbeing of people living with HIV and people living close to them after an HIV stigma reduction and wellness enhancement community intervention. Afr J AIDS Res. 2015;14(1):1–12.CrossRefPubMed
26.
go back to reference Prinsloo CD, Greeff M. A community, “Hub” network intervention for HIV stigma reduction: a case study. J Assoc Nurses AIDS Care. 2016;27(2):166–79.CrossRefPubMed Prinsloo CD, Greeff M. A community, “Hub” network intervention for HIV stigma reduction: a case study. J Assoc Nurses AIDS Care. 2016;27(2):166–79.CrossRefPubMed
27.
go back to reference Thomson DR, Rich ML, Kaigamba F, et al. Community-based accompaniment and psychosocial health outcomes in HIV-infected adults in Rwanda: a prospective study. AIDS Behav. 2014;18(2):368–80.CrossRefPubMed Thomson DR, Rich ML, Kaigamba F, et al. Community-based accompaniment and psychosocial health outcomes in HIV-infected adults in Rwanda: a prospective study. AIDS Behav. 2014;18(2):368–80.CrossRefPubMed
Metadata
Title
Systematic Review of Interventions for Depression for People Living with HIV in Africa
Authors
Sarah M. Lofgren
Noeline Nakasujja
David R. Boulware
Publication date
01-01-2018
Publisher
Springer US
Published in
AIDS and Behavior / Issue 1/2018
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-017-1906-3

Other articles of this Issue 1/2018

AIDS and Behavior 1/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.